News

08 February 2024 Lysa
Le LYSA s’enrichit d’une commission en ch...
27 November 2023 Calym
RedTalks #3 Saison 4: Towards Risk-Adapted a...
06 November 2023 Calym
RedTalks #2 Saison 4: IDH2 mutation in T-Cel...
16 October 2023 Calym
RedTalks #1 Saison 4: Novel insight into the...
15 September 2023 Lysarc
Publication of ALYCANTE study in Nature Medic...
LYSA-LYSARC announces the publication in Nature Medicine of the ALYCANTE s...
04 July 2023 Calym
Launch of the 1st edition of the OncoSTART Su...
29 June 2023 Calym
CALYM is proud to present the new version of ...
29 June 2023 Calym
RedTalks #7 Saison 3: MYC-translocated leuke...
06 June 2023 Calym
OncoSTART Summit & PhDMeeting Oncology J...
28 April 2023 Calym
RedTalks #6 Saison 3: Metabolic Regulation o...
23 March 2023 Calym
RedTalks #5 Saison 3: Combining glofitamab w...
23 February 2023 Calym
RedTalks #4 Saison 3: Pathogenesis of Hodgki...
18 January 2023 Calym
RedTalks #3 Saison 3: Understanding the role...
21 December 2022 Calym
The CeVi CAR-T collection, which gathers samp...
14 December 2022 Calym
CALYM and Embleema sign a strategic partnersh...
02 December 2022 Lysa
LYSA at ASH 2022
The 64th ASH Annual Meeting and Exposition will be held December 10-13, 202...
02 December 2022 Calym
Congratulations to the 2 new winners of the C...
18 November 2022 Calym
RedTalks #2 Saison 3: Targeting the Common P...
25 October 2022 Calym
RedTalks #1 Saison 3: The Single-Cell Pathol...
19 October 2022 Lysa
Launch of the TRANSCRIPT study
The objective of the TRANSCRIPT study is to know if autotransplantation red...
18 October 2022 Calym
The CALYM call for projects: an investment of...
22 September 2022 Lysa
Publication LYSA dans Nature Medicine | DESCA...
L’article du Pr Emmanuel Bachy à propos de l'étude DESCAR-T vient d’...
08 July 2022 Calym
Carnot CALYM Institute Activity Report 2021
24 June 2022 Calym
Euranova and the Carnot CALYM Institute combi...
Private Research and Development (R&D) center Euranova, specialized in data...